This invention relates generally to compositions and methods relating to hypertension. The present invention provides a method of enhancing the activity of Cyp 4A14 by administering an agent thatenhances the activity of Cyp 4A14 as well as a method of inhibiting the activity of Cyp 4A14 by administering an agent that inhibits the activity of Cyp 4A14. Further provided, is a method of enhancing the activity of Cyp 4A12 by administering an agent that enhances the activity of Cyp 4A12 as well as a method of inhibiting the activity of Cyp 4A12 by administering an agent that inhibits the activity of Cyp 4A12. A method of enhancing the activity of Cyp 4A12 by administering an agent that inhibits the activity of Cyp 4A14 is also provided. The invention also provides a method of inhibiting the activity of Cyp 4A12 by administering an agent that enhances the activity of Cyp 4A14. Further provided is a method of enhancing the activity of human Cyp 4A11 by administering an agent that enhances the activity of human Cyp 4A11 as well as a method of inhibiting the activity of human Cyp 4A11 by administering an agent that inhibits the activity of human Cyp 4A11.
本发明一般涉及与高血压有关的组合物和方法。本发明提供了一种通过施用增强 Cyp 4
A14 活性的制剂来增强 Cyp 4
A14 活性的方法,以及一种通过施用抑制 Cyp 4
A14 活性的制剂来抑制 Cyp 4
A14 活性的方法。进一步提供了一种通过施用增强 Cyp 4
A12 活性的制剂来增强 Cyp 4
A12 活性的方法,以及一种通过施用抑制 Cyp 4
A12 活性的制剂来抑制 Cyp 4
A12 活性的方法。本发明还提供了一种通过施用抑制 Cyp 4
A14 活性的制剂来增强 Cyp 4
A12 活性的方法。本发明还提供了一种通过施用增强 Cyp 4
A14 活性的制剂来抑制 Cyp 4
A12 活性的方法。本发明还提供了一种通过施用增强人Cyp 4A11活性的制剂来增强人Cyp 4A11活性的方法,以及一种通过施用抑制人Cyp 4A11活性的制剂来抑制人Cyp 4A11活性的方法。